TY - JOUR AU - Cheewaitsarakul, Peerapat AU - Chaiyaprasithi, Bansithi AU - Soontrapa, Suchai PY - 2006/06/01 Y2 - 2024/03/28 TI - Etoricoxib Compared with Fentanyl During Extracorporeal Shock Wave Lithotripsy (ESWL) JF - Insight Urology JA - Insight Urol VL - 27 IS - 1 SE - Original article DO - UR - https://he02.tci-thaijo.org/index.php/TJU/article/view/253747 SP - 30-33 AB - <div class="page" title="Page 1"><div class="layoutArea"><div class="column"><p><strong>Objective:</strong> The purpose of this study is to compare visual pain score and impression out- come between Etoricoxib and Fentanyl during ESWL.</p><p><strong>Method:</strong> A total of 31 patients scheduled for ESWL received one type of analgesic, either Etoricoxib 120 milligram orally 30 minutes before ESWL or Fentanyl 1 microgram / kilogram intravenously at the beginning of ESWL and change to another in next ESWL session. We com- pared visual pain score, side effect and impression outcome during ESWL.</p><p><strong>Results:</strong> This study showed no significant difference in the mean of visual pain score be- tween both analgesic drugs (Etoricoxib =5.39, Fentanyl = 6.00; p = 0.227). But in 21 patients (67.74%) had better impression outcome and prefered Etoricoxib for the third ESWL session.</p><p><strong>Conclusion:</strong> Etoricoxib 120 milligram orally is another alternative for pain control during ESWL. Etoricoxib had equivalent outcome in pain control but more convenient in oral form and had lesser side effect when compared to Fentanyl.</p></div></div></div> ER -